tradingkey.logo

Oncology Institute Inc

TOI
View Detailed Chart
3.390USD
-0.110-3.14%
Close 12/22, 16:00ETQuotes delayed by 15 min
330.76MMarket Cap
LossP/E TTM

Oncology Institute Inc

3.390
-0.110-3.14%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.14%

5 Days

-10.08%

1 Month

+8.31%

6 Months

+41.84%

Year to Date

+997.09%

1 Year

+1513.52%

View Detailed Chart

Key Insights

Oncology Institute Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 48/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.50.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Oncology Institute Inc's Score

Industry at a Glance

Industry Ranking
48 / 78
Overall Ranking
204 / 4578
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
6.500
Target Price
+104.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Oncology Institute Inc Highlights

StrengthsRisks
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 55.82% year-on-year.
Undervalued
The company’s latest PE is -5.35, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 39.72M shares, decreasing 16.39% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.55M shares of this stock.

Oncology Institute Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Oncology Institute Inc Info

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Ticker SymbolTOI
CompanyOncology Institute Inc
CEOVirnich (Daniel)
Websitehttps://theoncologyinstitute.com/

FAQs

What is the current price of Oncology Institute Inc (TOI)?

The current price of Oncology Institute Inc (TOI) is 3.390.

What is the symbol of Oncology Institute Inc?

The ticker symbol of Oncology Institute Inc is TOI.

What is the 52-week high of Oncology Institute Inc?

The 52-week high of Oncology Institute Inc is 4.880.

What is the 52-week low of Oncology Institute Inc?

The 52-week low of Oncology Institute Inc is 0.193.

What is the market capitalization of Oncology Institute Inc?

The market capitalization of Oncology Institute Inc is 330.76M.

What is the net income of Oncology Institute Inc?

The net income of Oncology Institute Inc is -53.01M.

Is Oncology Institute Inc (TOI) currently rated as Buy, Hold, or Sell?

According to analysts, Oncology Institute Inc (TOI) has an overall rating of Buy, with a price target of 6.500.

What is the Earnings Per Share (EPS TTM) of Oncology Institute Inc (TOI)?

The Earnings Per Share (EPS TTM) of Oncology Institute Inc (TOI) is -0.634.
KeyAI